AXT Inc. has announced a regulatory issue pertaining to its compliance with Nasdaq Listing Rule 5605(c)(2)$(A)$. Following the passing of Ms. Christine Russell, the company's Audit Committee currently consists of only two independent directors, falling short of the required three. Nasdaq has notified AXT Inc. of its non-compliance and has provided a cure period to rectify the situation. The company intends to appoint a new independent director to regain compliance before the deadline, which is either the next annual meeting of shareholders or by July 11, 2026, depending on which occurs first. AXT Inc. must submit documentation to Nasdaq demonstrating compliance within this timeframe.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.